Biomimetic Nanoparticles for Cancer Therapy: A Review of Recent Advances, Applications, and Bottlenecks

Biomimetic nanoparticles (BioM NPs) feature functionalization that imitates the biological surroundings, endowing them with biological structure and functioning. BioM NPs could be covered with biologically sourced materials and could contain synthetic antigen-presenting cells and structures. Whenever used in cancer diagnostics, BioM NPs outperform standard medications and comparable non-BioM NPs, particularly regarding circulation time, tissue penetration, delivery, and toxicity. The particles achieved extraordinary results by using cell material for BioM NPs, which avoids difficult bottom-up synthetic approaches that aim to emulate such intricate and diverse biological components. One area of this rapidly developing research that has gotten a lot of interest is the use of BioM NPs in the treatment of different cancers. However, to the best of our knowledge, no published study has primarily analysed current improvements in BioM NPs for cancer therapy, taking into account the most common tumours and processes. As a result, the purpose of our present review study is to address this gap first. The discussion will next go to the numerous recent advances in BioM NPs for cancer therapy. This will cover the mechanics and procedures of BioM NPs, as well as their utilization in therapeutics. This paper then summarizes existing knowledge and investigates the numerous limitations and promise of synthetic BioM NPs for cancer therapy. This review aims to provide researchers with an overview of the current research and technological development of BioM NPs for cancer therapy. It serves as a guide for integrating BioM NPs into cancer research and future nanomedicine applications.